Company news
Conneqt Health Limited (ASX:CQT) news
Conneqt Health Limited news releases on 6ix. Latest, Jan 11, 2018: AtCor and PhysioAge Systems announce supply agreement
Press releases — page 4
AtCor and PhysioAge Systems announce supply agreement
January 10, 2018
AtCor secures $1.0 million new pharmaceutical trial contract
December 14, 2017
AtCor appoints Craig Cooper as CEO
November 30, 2017
Chairmans address to 2017 AGM
November 29, 2017
Tax Refund
October 30, 2017
Security Purchase Plan
September 7, 2017
Full Year Statutory Accounts
August 31, 2017
Share Purchase Plan
August 29, 2017
Share Placement
August 8, 2017
AtCor restructures operations
August 2, 2017
AtCor Signs New Agreement
July 31, 2017
Secures $0.8 million new pharmaceutical trials contracts
July 12, 2017
AtCor Signs New Network Health Systems Agreement
June 6, 2017
Business update and Strategic Review
May 18, 2017
AtCor Signs Local Health System Agreement
February 23, 2017
Study Finds Central Aortic Waveform Improves HF Treatment
February 15, 2017
Tax refund
February 13, 2017
Positive Novartis drug trial using SphygmoCor XCEL
January 22, 2017
AtCor completes share placement
November 15, 2016
Leading research team highlights role of SphygmoCor
November 4, 2016
FY2016 results
August 29, 2016
Large national plan to reimburse SphygmoCor test
July 6, 2016
$0.6 million pharmaceutical trial extension
June 29, 2016
SphygmoCor selected for US publicly funded study
March 30, 2016
US$1.1 million pharmaceutical contract
March 29, 2016
Patent granted in USA
March 8, 2016
FDA clearance for Oscar 2 with SphygmoCor inside
March 2, 2016
CPT-1 Reimbursement Update
February 28, 2016
Patent granted in Japan
February 16, 2016
US$0.6m new pharmaceutical trial contract
February 11, 2016
Market update
February 10, 2016